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The p53 family of proteins contains two members that have been implicated in sensitization of cells 
and organisms to genotoxic stress, i.e., p53 itself and p73. In vitro, lack of either p53 or p73 can pro-
tect certain cell types in the adult organism against death upon exposure to DNA damaging agents. 
The present study was designed to assess the relative contribution of p53 to radiation resistance of 
an emerging vertebrate model organism, i.e., zebrafish embryos. Consistent with previous reports, 
suppressing p53 protein expression using antisense morpholino oligonucleotides (MOs) increased 
survival and reduced gross morphological alterations in zebrafish embryos exposed to ionizing 
radiation. By contrast, a pharmacological inhibitor of p53 function [Pifithrin-α (PFTα)] caused 
developmental abnormalities affecting the head, brain, eyes and kidney function and did not pro-
tect against lethal effects of ionizing radiation when administered at 3 hours post fertilization (hpf). 
The phenotypic abnormalities associated with PFTα treatment were similar to those caused by 
antisense MO knock down (kd) used to reduce p73 expression. PFTα also inhibited p73-dependent 
transcription of a reporter gene construct containing canonical p53-responsive promoter sequences. 
Notably, when administered at later stages of development (23 hpf), PFTα did not cause overt devel-
opmental defects but exerted radioprotective effects in zebrafish embryos. In summary, this study 
highlights off-target effects of the pharmacological p53 inhibitor PFTα related to inhibition of p73 
function and essential roles of p73 at early but not later stages of zebrafish development.
Introduction
The genotoxic stress response is one of the most widely studied phenomena in biology and the 
efforts of many groups have provided a detailed understanding of the molecular determinants of 
this homeostatic mechanism (reviewed in refs. 1–3). Yet, the current understanding of the effects of 
genotoxic stress on whole organisms is curtailed by the fact that many of the mechanistic insights are 
based on experiments with cultured cells. These shortcomings are compounded by pitfalls associated 
with the preferential use of immortalized or transformed cells.4 In recognition of these problems, 
many groups have resorted to studying the DNA damage response in experimental animals, particu-
larly genetically engineered mice. These efforts have contributed considerably to the understanding 
of molecular determinants of the in vivo genotoxic stress response including Ku,5,6 DNA-PK,7 DNA 
ligase IV,8 ATM,9 ATR,10 Chk111 and Chk2.12 In addition, these studies confirmed a central role of the 
tumor suppressor p53 in the genotoxic stress response (reviewed in refs. 13 and 14). 
The present study was undertaken to explore molecular determinants of the genotoxic stress 
response in an emerging animal model system, i.e., zebrafish embryos. Zebrafish represents a 
vertebrate species with many similarities to mammals. Yet, they breed prolifically and are ame-
nable to large-scale phenotypic screening facilitated by the fact that they are transparent during 
organogenesis. Importantly, ‘knockdown’ strategies using antisense MOs have been developed in 
this species to investigate protein function in 
the in vivo context. Zebrafish are attractive 
not only to model human diseases but also as 
tools in drug discovery.15 We have previously 
reported that zebrafish embryos provide a 
rapid, facile system to identify pharmacologi-
cal modifiers of the radiation response.16 Here, 
we extend these studies to assess the contribu-
tion of endogenous modifiers of the radiation 
response to radiation-induced morbidity and 
mortality by focusing on pharmacological and 
genetic inhibition of p53 function.
Results and Discussion
Time- and dose-dependent effects of ioniz-
ing radiation on zebrafish embryo survival.
Previously, we observed that radiation sen-
sitivity of zebrafish embryos was different at
distinct developmental stages and progres-
sively decreased between 2 to 8 hours post
fertilization (hpf ).16 Here, we extend this earlier 
study by assessing embryo survival after expo-
sure to increasing radiation doses up to 72 h 
after radiation. These experiments confirmed 
progressive radioresistance at successive stages 
of development (not shown). To determine 
the consequences of inhibiting translation of 
specific gene products by antisense MO kd for 
radiation resistance of the developing embryo 
we performed all subsequent experiments in 
embryos which were irradiated at 24 hpf. This 
was based on the consideration that, at this time 
point, target protein expression is sufficiently 
suppressed by antisense MO kd and remains 
low for extended time periods up to 4 days post 
fertilization (dpf ).17 Dose-dependent survival 
upon radiation exposure at 24 hpf revealed 
100% lethality scored at 6–7 dpf (40 Gy) with 
an LD50 of 20 Gy.18 To monitor the effects of 
p53 expression on radiation sensitivity as it 
relates to both, mortality and tissue-specific 
effects, we thus performed experiments at 20 
or 40 Gy.
Reduced p53 expression is associated 
with radioprotection of zebrafish embryos. 
Zebrafish embryos harboring homozygous 
missense p53 mutations exhibit increased 
resistance to the deleterious effects of ionizing 
radiation.19 We determined whether suppressing 
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p53 expression by antisense MOs20 similarly induced a radioresistant 
phenotype. We observed that p53-targeted MO kd markedly improved 
survival of zebrafish embryos irradiated with 20 Gy at 24 hpf (Fig. 1A) 
whereas coinjection of capped p53 mRNA restored radiation sensitivity 
(Fig. 1B). Similarly, p53-targeted MO kd markedly reduced the incidence 
and severity of radiation-induced morphological defects, notably defects 
in midline development that manifest as dorsal curvature of the body 
axis (Fig. S1). These results were similar to results by Duffy and Wick-
strom published during preparation of this manuscript.21 In addition, 
p53-targeted MO kd markedly reduced the extent of radiation-induced 
apoptosis as determined by acridine orange staining (Fig. 1C). 
Effects of the pharmacological p53 inhibitor PFTα on development 
and radiation sensitivity of zebrafish embryos. PFTα was originally 
identified as an inhibitor of p53-dependent transcription22 and it reduced 
the sensitivity of mice to the deleterious effects of ionizing radiation.23 
Based on these previous studies we tested whether PFTα also protected 
zebrafish embryos against radiation-associated toxicity (Fig. 2A). Unex-
pectedly, when added to zebrafish embryos at 3 hpf (sphere stage), PFTα 
(2 μM) caused malformations affecting the head region and led to the 
development of massive edema affecting the whole body of treated fish 
at later stages of development (Fig. 2B and Table 1). Furthermore, it has 
been described earlier that PFTα treatment also reduces overall survival 
of zebrafish embryos.21 These results together raised the question whether 
PFTα exerted effects on molecular targets other than p53, which confound 
potential radioprotective properties of PFTα in the zebrafish embryo.
PFTα treatment mimics morphological effects associated with knock-
down of p73 expression in zebrafish embryos. P73 is a likely candidate 
for off-target effects of PFTα because p73 binds to and transactivates 
p53 responsive promoters.24 Thus, we determined whether suppression 
of p73 expression by antisense MO kd caused developmental defects 
similar to those observed in PFTα treated embryos. A previous report 
showed that targeting p73 adversely affected development of the head 
region, i.e., the olfactory system, the telencephalon and the pharyngeal 
arches of zebrafish embryos.25 In addition, p73 is expressed at high levels 
in the developing kidneys.26 We observed that p73-targeted antisense 
MO-mediated kd induced head region abnormalities (Fig. 3A) and led 
to liquid accumulation affecting the whole body of treated fish (Fig. 4 
and Table 2). These changes were very similar to the morphological 
alterations observed in PFTα-treated fish (Fig. 2B). Furthermore, alcian 
blue staining revealed severe disturbances of branchial arch development 
associated with either PFTα treatment or p73-targeted antisense MO kd 
(Fig. 3B). These defects were, at least partially, reversed by coinjection 
of G-capped p73 mRNA and not observed in embryos injected with p73 
mismatched antisense MO.
Impaired kidney function in zebrafish treated with PFTα and p73 
morpholinos. This is the first report of edema formation upon treatment 
of developing embryos with p73-targeted antisense MO kd. We hypoth-
esized that this phenotype was due to impaired renal clearance consistent 
with high-level expression of p73 in the developing kidneys.26 To address 
this issue we used a renal function assay, which measures retention of a 
fluorescent dextran within 24 h after injection into the cardiac venous-
sinus.27 As compared to control fish receiving mismatch antisense MO, 
the p73-targeted antisense MO kd caused markedly reduced clearance 
of this contrast agent (Fig. 5). In contrast, control p53-specific antisense 
MO kd did not affect dextran retention. Importantly, PFTα treatment not 
only led to liquid accumulation in fish embryos in a manner similar to 
p73-targeted antisense MO kd but it also increased dextran retention in 
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Figure 1. Antisense morpholino oligonucleotides (MOs) targeted to 
p53 increase embryo survival and reduce ionizing radiation-induced 
apoptosis evident in the head and trunk regions. (A) Embryo survival. 
Triplicate dishes of 60 embryos each were scored for live embryos daily 
after 20 Gy IR administered at 24 hpf. Necrotic dissolution or absent 
heartbeat were considered criteria for embryo death. (B) Restoration of 
IR sensitivity by restoring p53 expression using G-capped zebrafish p53 
mRNA. Triplicate dishes of 60 embryos each were scored as described 
above at 6 dpf (5 days post IR). Asterix (*) p53kd vs p53kd-p53 mRNA; p 
< 0.05; t-test, one-tailed). (C) Attenuation of IR-induced apoptosis by p53 
kd as assessed by quantification of acridine orange (AO) staining at 30 
hpf. Sixty embryos per condition (Control, phenol red control; p53 mm, 
mismatch antisense MO; p53 kd, p53 antisense MO; p53 kd-p53mRNA, 
rescue coinjection with p53 antisense MO and p53 G-capped mRNA) 
were pooled and stained with AO as described in Materials and Methods. 
Pooled embryos were transferred to 95% ethanol for 15 minutes to 
extract the AO for fluorescence determination. Triplicate measurements 
for each condition were performed on a FL600 microplate fluorescence 
reader (Bio-Tek) and normalized to control background fluorescence 
and reported as relative fluorescence units (RFU).
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a similar fashion. In these experiments, kidney function was tested at 3 
dpf and prior to the development of edema to avoid confounding effects 
of the liquid accumulation on embryonal kidney function.
An alternative explanation for the profound edema in zebrafish embryos 
following IR exposure is that this effect was caused by reduced cardiac 
function.28 To investigate this possibility, we performed time-lapse 
microscopy of cardiac contractility in control and irradiated fish embryos. 
Quantitative analysis of the images revealed only marginal effects of 
either PFTα treatment or p73-specific antisense MO kd on heart rate 
and blood flow (not shown). Collectively, these results suggest that the 
edema observed in PFTα and p73 antisense MO kd zebrafish embryos is 
due primarily to compromised renal function.
PFTα inhibits p73-dependent transactivation of a p53-respon-
sive promoter construct. The striking similarities in developmental 
abnormalities caused by either PFTα treatment of suppression of p73 
expression raised the question whether PFTα targeted not only p53-
dependent but also p73-dependent transcription. Using a p53 responsive 
reporter gene construct and zebrafish p53 and p73 expression plasmids 
cotransfected into Saos-2 cells we observed that PFTα not only inhibited 
p53-dependent transcription but also p73-dependent transcription in a 
dose-dependent manner (Fig. 6).
It should be noted that administration of PFTα shortly before radiation 
(i.e., at 23 hpf ) did not cause developmental abnormalities either of the 
craniofacial region or systemic edema and provided a measure of protec-
tion against radiation similar to that observed in p53 antisense MO kd 
fish (Fig. S1). This result indicates that p73 serves essential functions 
during the first 24 h of zebrafish development but is less relevant at later 
developmental stages and, presumably, in the adult organism. This cir-
cumstance also explains why inhibition of p73 function by PFTα has not 
been obvious in previous in vitro or in vivo studies in adult mice.
In summary, this report demonstrates the utility of the zebrafish 
model system in characterizing drug effects and highlights previously 
unrecognized effects of the p53 inhibitor PFTα related to inhibition 
of p73 function. Lack of either p53 or p73 function is associated with 
chemoresistance of transformed cells.29 Furthermore, p73 is induced 
after DNA damage by the checkpoint kinases Chk1 and Chk2.30 Based 
on these results, p73 has been considered as the “assistant” guardian 
of the genome that acts in concert with p53 to limit propagation of 
cells with damaged DNA.31 Since we observed that PFTα inhibits not 
only p53-dependent but also p73-dependent transcription the overall 
radioprotective effect of PFTα as observed in mice may, thus, be due to 
inhibition of p53 and p73 function. Indeed, short-term pharmacological 
inhibition of both, p53 and p73 may be superior to inhibition of p53 
alone to protect normal adult cells and tissues against deleterious effects 
of radiation.
Materials and Methods
Embryo harvesting and maintenance. Zebrafish husbandry, embryo 
collection, dechorionation and embryo maintenance were performed 
according to accepted standard operating procedures32 and with approval 
by the Institutional Animal Care and Use Committee at Thomas Jeffer-
son University. Zebrafish were maintained in the Zebrafish Core Facility 
of the Kimmel Cancer Center at Thomas Jefferson University at 28.5°C 
on a 14-h light/10-h dark cycle.
Zebrafish morphology by visual analysis. For visual analysis, zebrafish 
embryos were anesthetized with 0.003% tricaine, placed on 3% meth-
ylcellulose on a glass depression slide and analyzed using an Olympus 
BX51 microscope (Olympus, Melville, NY) at 4x magnification. Images 
were recorded using a SPOT camera and SPOT Advanced software 
(SPOT Diagnostic Instruments, Sterling Heights, MI).
Targeted knock down of gene expression. Antisense MO sequences 
targeting p53, p73 and controls (5 base mismatches; p53 mm, p73 mm) 
were as described.20,25 For microinjection, a 0.5 mM oligonucleotide solu-
tion was prepared in 10x phosphate-buffered saline solution, diluted 9:1 
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Figure 2. PFT-α (2 μM) administered to zebrafish embryos at 3 hpf does not protect against the lethal effects of IR and is associated with developmental 
abnormalities. (A) Embryo survival scored as described in Figure 1A. (B) Embryo morphology in the different experimental conditions as indicated. 
Representative embryos were digitally photographed at 4x magnification and processed using NIH ImageJ software.
Table 1. 
Incidence of whole body edema caused by PFTα treatment
 Normal Edema  Total  Edema (%)
Control  77  0  77  0
PFTα (2μM)  18  29  47  62
Triplicate dishes (30 embryos each per condition) of live embryos at 7 dpf were scored for edema as shown 
in Figure 2B and results expressed as percent edema.
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(v:v) with Phenol Red dye, and ~1 nL injected into 1–4 cell embryos 
using a nitrogen gas pressure injector (Harvard Apparatus, Cambridge, 
MA). To account for non-specific effects of MO oligonucleotides, rescue 
experiments were carried out by coinjection of MOs with G-capped 
mRNA of the respective target gene. To this end, triplicate dishes of 60 
embryos were injected with 4.5–7.5 pg of mRNA generated by clon-
ing the zebrafish p53 cDNA or p73 cDNA into the pCS2+ vector and
producing mRNA with the mMessage-mMachine SP6 kit (Ambion, 
Austin, TX).
Radiation exposure and PFTα protection. Triplicate dishes (60 embryos 
each) were irradiated at 24 hpf (20 Gy) using 250 kVp X-rays (PanTak, East 
Haven, CT) at 50 cm source-to-skin with a 2-mm aluminum filter. Dosi-
metric calibration was performed before each experiment using a thimble 
ionization chamber (Victoreen; Elimpex-Medizintechnik, Moedling, Aus-
tria) with daily temperature and pressure correction. Pifithrin-α (EMD 
Biosciences, San Diego, CA) was solubilized in DMSO and diluted with 
embryo media. PFTα was applied 30 minutes prior to IR.
Kidney function assay. A 1% solution of rhodamine-labeled dextran (10 
kDa; Molecular Probes) in PBS was injected (3 dpf ) using glass micropi-
pets into the cardiac venous sinus of embryos immobilized in 3% methyl 
cellulose. Prior to injection, embryos were anesthetized using a 0.003% 
tricaine solution in egg water.33 After injection, the embryos were washed 
in egg water for 10 minutes and placed back into 3% methylcellulose 
on a glass depression slide. Fluorescence was quantitated using ImageJ 
software (NIH, USA). The analysis was repeated at 24 h after dextran 
injection. Percent dextran retention at 24 h was calculated using the for-
mula: (intensity 24 h/intensity 0 h) X 100.
Figure 3. PFT-α treatment (2 μM at 3 hpf) affects cranio-facial develop-
ment reducing brain, eye and auditory organ size. (A) Embryo head 
morphology at 6 dpf. Representative embryos were digitally photo-
graphed at 10x magnification and processed using NIH ImageJ software 
(a) snout, (b) eyes, (c) auditory cup. (B) Alcian blue staining (described 
in Materials and Methods) of cartilage shows markedly abnormal 
cranio-facial development associated with PFT-α treatment and with 
p73 antisense MO kd.
a
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Figure 4. Phenotypic abnormalities associated with PFT-α treatment 
are similar to those caused by MO-mediated p73 kd. PFT-α was admin-
istered at 3 hpf. Embryo morphology and rescue by G-capped mRNA. 
Representative embryos were digitally photographed at 4x magnification 
and processed using NIH ImageJ software.
Table 2. Incidence of whole body edema caused by p73kd
 Normal Edema  Total  Edema (%)
Control  219  1  220  0
p73 MO  121  126  247  51
p73 mm  64  4  68  6
p73 MO/mRNA  151  37  188  20
Live embryos at 7 dpf were scored for edema as described in Figure 4 and results expressed as 
percent edema.
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Alcian blue staining. Alcian blue staining was performed according to 
Neuhauss et al.,34 with the following modifications. Embryos (4 dpf ) 
were fixed overnight in Davidson’s Solution (Electron Microscopy Sci-
ences, Hatfield, PA) and rinsed 3x for 10 min in PBS and transferred to 
neutral buffered formalin for 2 days at 4°C. The embryos were then trans-
ferred into distilled water and stored at 4°C. For Alcian blue staining, the 
samples were washed in PBT (0.1% Tween-20 in PBS) and transferred 
into 30% H2O2 (Sigma, St. Louis, MO) and bleached for 4–5 hours or 
until eyes became translucent. After bleaching, the embryos were rinsed 
in PBS for 15 min and transferred to filtered Alcian Blue solution (1% 
conc HCl, 70% Ethanol, 0.1% Tween-20) and stained overnight. The 
stain was cleared with acidic ethanol (5% conc HCl, 70% ethanol).
Acridine orange staining. Zebrafish embryos were dechorionated and 
placed in 50 μg/ml of acridine orange (Sigma) in fish water. After 30 min 
of staining, embryos were washed 3x for 10 min in PBS. Pooled embryos 
were transferred to 95% ethanol for 15 minutes to extract the AO for 
fluorescence determination. Triplicate measurements for each condition 
were performed on a FL600 microplate fluorescence reader (Bio-Tek) 
and normalized to control background fluorescence and reported as rela-
tive fluorescence units (RFU).
In vitro reporter gene assays. Saos-2 cells (ATCC Rockville, MD) were 
cultured in DMEM supplemented with 10% fetal calf serum. Cells were 
cultured to 60–70% confluence and transferred to 48-well plates at a 
density of 2.6 x 104 cells/well. Cells were transfected with three plasmids 
Figure 5. Reduced kidney function by either PFT-α treatment or p73 kd as determined by increased fluorescent dextran retention. (A) Rhodamine labeled 
dextran staining is described in Materials and Methods. Representative images are shown at 0 and 24 h. (B) Quantification of dextran label retention at 24 h 
after dye injection. Three embryos per condition were quantified for dye retention using NIH imageJ software.
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using Fugene (Roche). The p53 reporter plasmid was constructed by 
inserting the synthetic p53-responsive promoter containing 14 tandem 
p53 enhancer elements and a TATA-box (Pathdetect p53-cis reporter, 
Stratagene) into the pRLnull plasmid (Promega) to drive the Renilla 
luciferase gene (p53 pr-RLuc). For normalization, a B-galactosidase 
reporter plasmid was used (pCMV-Bgal;35). Renilla luciferase activity was 
measured 48 hrs after transfection using the Dual-Luciferase Reporter 
Assay System (Promega, Madison, WI) and B-gal activity was measured 
using the Beta-Glo Reporter Assay System (Promega, Madison, WI) 
according to the manufacturer’s specifications. Cells were treated 
with PFTα 15 minutes before transfection. Chemiluminescence was 
measured using a Veritas Microplate luminometer (Turner Biosystems,
Sunnyvale, CA).
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